(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -293.48%-57.05M | -2.71%-92.52M | -1,772.08%-52.48M | -140.35%-25.24M | 98.23%-302.65K | 77.92%-14.5M | 72.45%-90.08M | 102.11%3.14M | 83.90%-10.5M | 84.64%-17.06M |
Net income from continuing operations | -9.49%-18.04M | 69.21%-20.29M | 86.33%-4.08M | -28.59%-7.47M | 143.17%7.74M | -33.77%-16.48M | 7.83%-65.9M | 40.37%-29.84M | -141.08%-5.81M | -47.02%-17.93M |
Operating gains losses | 327.26%327.5M | 744.50%8.76M | 723.41%14.17M | -40.41%-4.76M | -1,065.80%-77.3M | 1,546.73%76.65M | 103.26%1.04M | 107.40%1.72M | 55.61%-3.39M | 2,560.40%8M |
Depreciation and amortization | -4.82%520.46K | -13.27%2.05M | -12.72%512.81K | -13.60%512.81K | -19.06%478.78K | -7.71%546.85K | -35.03%2.37M | -58.45%587.53K | -41.46%593.53K | -41.47%591.52K |
Asset impairment expenditure | --4.96M | --0 | ---- | ---- | ---- | --0 | -20.69%13.87M | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | 614.63%1.84M | -187.13%-13.48M | -229.04%-15.66M | 1,163.97%2.49M | -98.80%42.49K | -1,530.27%-357.35K | -11.43%15.48M | -44.40%12.14M | 94.19%-234.32K | 55.99%3.55M |
Remuneration paid in stock | 71.84%1.62M | -81.62%2.92M | 467.52%1.09M | 42,616.90%387.33K | -92.81%501.6K | -89.21%941.29K | -62.20%15.89M | -99.34%192.06K | -100.02%-911 | 10.94%6.97M |
Other non cashItems | -383.36%-375.09M | 5.24%-73.22M | -4,330.66%-49.16M | -261.70%-17.7M | 500.42%71.23M | -39.21%-77.6M | 74.74%-77.27M | 100.81%1.16M | 92.25%-4.89M | 83.28%-17.79M |
Change In working capital | -119.63%-353.15K | -4.18%4.27M | -54.02%1.52M | 20.86%3.91M | -545.46%-2.97M | 209.82%1.8M | 172.58%4.45M | 246.74%3.31M | -47.69%3.24M | 73.14%-459.76K |
-Change in receivables | -299.12%-95.98K | 137.83%13.07K | -162.65%-47.91K | 294.84%186.91K | -3,693.15%-101.88K | -94.03%-24.05K | ---34.54K | --76.47K | ---95.93K | ---2.69K |
-Change in prepaid assets | -465.56%-637.61K | -236.32%-945.07K | -531.60%-1.09M | 3.95%1.38M | -5,606.73%-1.4M | 119.20%174.42K | 56.43%693.29K | -88.12%253.13K | 338.13%1.32M | 110.75%25.47K |
-Change in payables and accrued expense | -76.92%380.44K | 37.04%5.2M | -10.73%2.66M | 16.93%2.35M | -203.27%-1.46M | 329.80%1.65M | 218.75%3.79M | 167.99%2.98M | -70.20%2.01M | 67.27%-482.54K |
Interest paid (cash flow from operating activities) | ---- | ---3.52M | ---873.48K | ---2.61M | ---- | ---- | --0 | --0 | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -293.48%-57.05M | -2.71%-92.52M | -1,772.08%-52.48M | -140.35%-25.24M | 98.23%-302.65K | 77.92%-14.5M | 72.45%-90.08M | 102.11%3.14M | 83.90%-10.5M | 84.64%-17.06M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 319.64K | 0 | 0 | -170.62%-2.67M | ||||||
Net PPE purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | -4,392.40%-1.41M | ---- | ---- | ---- |
Net business purchase and sale | --319.64K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | -2,483.50%-1.26M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --319.64K | --0 | ---- | ---- | ---- | --0 | -170.62%-2.67M | ---- | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 323.68%59.31M | 7.45%94.62M | 39,331.31%57.17M | 162.13%23.77M | -102.24%-318.75K | -78.43%14M | -73.48%88.06M | -100.10%-145.71K | -86.40%9.07M | -86.83%14.22M |
Net issuance payments of debt | --0 | -91.29%4.63M | 121.85%368.23K | -101.30%-59.03K | --0 | -90.66%4.32M | --53.12M | ---1.69M | --4.55M | --4.02M |
Net common stock issuance | ---- | 139.04%4.53M | 191.36%4.53M | --0 | ---- | ---- | -203.71%-11.6M | 129.28%1.55M | 100.00%4 | -724.79%-5.26M |
Proceeds from stock option exercised by employees | --53.08K | -86.30%94.88K | --94.88K | --0 | --0 | --0 | -71.84%692.28K | --0 | --0 | -52.59%647.28K |
Net other financing activities | 512.23%59.26M | 86.19%85.36M | 360,139.08%52.17M | 427.20%23.83M | -102.15%-318.75K | -63.51%9.68M | -86.25%45.85M | -100.01%-14.49K | -93.88%4.52M | -86.19%14.82M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 323.68%59.31M | 7.45%94.62M | 39,331.04%57.17M | 162.13%23.77M | -102.24%-318.75K | -78.43%14M | -73.48%88.06M | -100.10%-145.71K | -86.40%9.07M | -86.83%14.22M |
Net cash flow | ||||||||||
Beginning cash position | 37.12%6.73M | -46.45%4.91M | -53.94%2.14M | -34.12%3.68M | -46.89%4.4M | -46.45%4.91M | 2,658.72%9.16M | -56.32%4.66M | -39.36%5.59M | -29.52%8.29M |
Current changes in cash | 616.53%2.58M | 144.69%2.1M | 1,347.41%4.69M | -2.46%-1.47M | 78.11%-621.4K | 32.81%-499.7K | -152.90%-4.69M | 121.61%323.75K | -199.20%-1.43M | -12.76%-2.84M |
Effect of exchange rate changes | 2,864.77%104.29K | -163.11%-275.5K | -40.17%-102.94K | -113.64%-68.33K | -173.30%-100.47K | 97.06%-3.77K | 1,195.49%436.55K | -3,671,800.00%-73.43K | 219,679.82%501.1K | 561.79%137.06K |
End cash Position | 113.80%9.41M | 37.12%6.73M | 37.12%6.73M | -53.94%2.14M | -34.12%3.68M | -46.89%4.4M | -46.45%4.91M | -46.45%4.91M | -56.32%4.66M | -39.36%5.59M |
Free cash from | -293.48%-57.05M | -1.12%-92.52M | -3,137.88%-52.48M | -140.35%-25.24M | 98.23%-302.65K | 77.92%-14.5M | 72.02%-91.49M | 101.16%1.73M | 83.90%-10.5M | 84.64%-17.06M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.